Authors:
Sutinen, E
Jyrkkio, S
Gronroos, T
Haaparanta, M
Lehikoinen, P
Nagren, K
Citation: E. Sutinen et al., Biodistribution of [C-11]methylaminoisobutyric acid, a tracer for PET studies on system A amino acid transport in vivo, EUR J NUCL, 28(7), 2001, pp. 847-854
Authors:
Bruck, A
Portin, R
Lindell, A
Laihinen, A
Bergman, J
Haaparanta, M
Solin, O
Rinne, JO
Citation: A. Bruck et al., Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus, NEUROSCI L, 311(2), 2001, pp. 81-84
Authors:
Lamusuo, S
Jutila, L
Ylinen, A
Kalviainen, R
Mervaala, E
Haaparanta, M
Jaaskelainen, S
Partanen, K
Vapalahti, M
Rinne, J
Citation: S. Lamusuo et al., [F-18]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage, ARCH NEUROL, 58(6), 2001, pp. 933-939
Authors:
Nurmi, E
Ruottinen, HM
Kaasinen, V
Bergman, J
Haaparanta, M
Solin, O
Rinne, JO
Citation: E. Nurmi et al., Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT, ANN NEUROL, 47(6), 2000, pp. 804-808
Authors:
Laihinen, A
Ruottinen, H
Rinne, JO
Haaparanta, M
Bergman, J
Solin, O
Koskenvuo, M
Marttila, R
Rinne, UK
Citation: A. Laihinen et al., Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [F-18]6-fluorodopa PET, J NEUROL, 247, 2000, pp. 110-113
Authors:
Ruottinen, HM
Partinen, M
Hublin, C
Bergman, J
Haaparanta, M
Solin, O
Rinne, JO
Citation: Hm. Ruottinen et al., An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome, NEUROLOGY, 54(2), 2000, pp. 502-504
Authors:
Rinne, JO
Portin, R
Ruottinen, H
Nurmi, E
Bergman, J
Haaparanta, M
Solin, O
Citation: Jo. Rinne et al., Cognitive impairment and the brain dopaminergic system in Parkinson disease - [F-18]fluorodopa positron emission tomographic study, ARCH NEUROL, 57(4), 2000, pp. 470-475
Authors:
Laakso, A
Vilkman, H
Alakare, B
Haaparanta, M
Bergman, J
Solin, O
Peurasaari, J
Rakkolainen, V
Syvalahti, E
Hietala, J
Citation: A. Laakso et al., Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography, AM J PSYCHI, 157(2), 2000, pp. 269-271
Authors:
Laakso, A
Vilkman, H
Kajander, J
Bergman, J
Haaparanta, M
Solin, O
Hietala, J
Citation: A. Laakso et al., Prediction of detached personality in healthy subjects by low dopamine transporter binding, AM J PSYCHI, 157(2), 2000, pp. 290-292
Authors:
Hietala, J
Syvalahti, E
Vilkman, H
Vuorio, K
Rakkolainen, V
Bergman, J
Haaparanta, M
Solin, O
Kuoppamaki, M
Eronen, E
Ruotsalainen, U
Salokangas, RKR
Citation: J. Hietala et al., Depressive symptoms and presynaptic dopamine function in neuroleptic-naiveschizophrenia, SCHIZOPHR R, 35(1), 1999, pp. 41-50
Authors:
Rinne, JO
Bergman, J
Ruottinen, H
Haaparanta, M
Eronen, E
Oikonen, V
Sonninen, P
Solin, O
Citation: Jo. Rinne et al., Striatal uptake of a novel PET ligand, [F-18]beta-CFT, is reduced in earlyParkinson's disease, SYNAPSE, 31(2), 1999, pp. 119-124
Authors:
Takala, TO
Nuutila, P
Katoh, C
Luotolahti, M
Bergman, J
Maki, M
Oikonen, V
Ruotsalainen, U
Gronroos, T
Haaparanta, M
Kapanen, S
Knuuti, J
Citation: To. Takala et al., Myocardial blood flow, oxygen consumption, and fatty acid uptake in endurance athletes during insulin stimulation, AM J P-ENDO, 277(4), 1999, pp. E585-E590
Authors:
Suhonen-Polvi, H
Varho, T
Metsahonkala, L
Haataja, L
Ruotsalainen, U
Haaparanta, M
Bergman, J
Solin, O
Aarimaa, T
Holopainen, I
Vainionpaa, L
Manner, T
Jaaskelainen, S
Renlund, M
Sillanpaa, M
Aula, P
Citation: H. Suhonen-polvi et al., Increased brain glucose utilization in Salla disease (free sialic acid storage disorder), J NUCL MED, 40(1), 1999, pp. 12-18
Authors:
Rinne, JO
Ruottinen, H
Bergman, J
Haaparanta, M
Sonninen, P
Solin, O
Citation: Jo. Rinne et al., Usefulness of a dopamine transporter PET ligand [F-18]beta-CFT in assessing disability in Parkinson's disease, J NE NE PSY, 67(6), 1999, pp. 737-741
Authors:
Turpeinen, AK
Takala, TO
Nuutila, P
Axelin, T
Luotolahti, M
Haaparanta, M
Bergman, J
Hamalainen, H
Iida, H
Maki, M
Uusitupa, MIJ
Knuuti, J
Citation: Ak. Turpeinen et al., Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance - Studies with PET and 14(R, S)-[F-18]fluoro-6-thia-heptadecanoic acid, DIABETES, 48(6), 1999, pp. 1245-1250
Authors:
Laine, H
Katoh, C
Luotolahti, M
Yki-Jarvinen, H
Kantola, I
Jula, A
Takala, TO
Ruotsalainen, U
Iida, H
Haaparanta, M
Nuutila, P
Knuuti, J
Citation: H. Laine et al., Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy, CIRCULATION, 100(24), 1999, pp. 2425-2430
Authors:
Nuutinen, J
Minn, H
Bergman, J
Haaparanta, M
Ruotsalainen, U
Laine, H
Knuuti, J
Citation: J. Nuutinen et al., Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study, BR J CANC, 80(3-4), 1999, pp. 513-518